| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 41.379 | 52.967 | 65.312 | 57.876 | 49.143 | 33.929 | 31.330 | 59.145 | 55.041 | 47.739 |
| Total Income - EUR | 41.528 | 53.081 | 68.273 | 57.991 | 49.168 | 34.408 | 32.069 | 59.165 | 55.041 | 47.756 |
| Total Expenses - EUR | 11.344 | 20.663 | 23.934 | 23.857 | 25.509 | 5.042 | 4.204 | 4.887 | 12.840 | 15.968 |
| Gross Profit/Loss - EUR | 30.185 | 32.418 | 44.339 | 34.134 | 23.660 | 29.366 | 27.866 | 54.278 | 42.201 | 31.788 |
| Net Profit/Loss - EUR | 28.939 | 31.568 | 43.656 | 33.568 | 22.184 | 28.453 | 27.006 | 52.995 | 41.662 | 30.384 |
| Employees | 1 | 3 | 2 | 1 | 1 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Otorinomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.677 | 10.006 | 7.160 | 4.677 | 3.163 | 2.366 | 2.164 | 1.289 | 7.765 | 5.477 |
| Current Assets | 22.136 | 22.496 | 68.431 | 29.823 | 19.286 | 26.846 | 33.914 | 54.173 | 34.879 | 25.918 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 3.099 | 1.444 | 4.179 | 3.330 | 0 |
| Cash | 22.136 | 22.496 | 68.431 | 29.823 | 4.535 | 6.841 | 3.085 | 11.459 | 3.344 | 10.926 |
| Shareholders Funds | 31.124 | 31.621 | 74.742 | 33.619 | 22.235 | 28.502 | 35.715 | 53.044 | 41.710 | 30.433 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 689 | 881 | 848 | 880 | 214 | 710 | 363 | 2.418 | 934 | 962 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Otorinomed Srl